MENU

MMS MAXIMUS Forecast, Technical & Fundamental Analysis

Maximus Inc designs, develops, and delivers programs enabling people to access vital government services... Show more

A.I.Advisor
Nov 15, 2026

Maximus (MMS) Stock Forecast: Federal Health Demand and AI Automation Could Define the Next Growth Phase

Key Takeaways

  • Upcoming catalysts: Maximus is set to report fiscal 2026 fourth-quarter results, with investor attention focused on the status of the U.S. Department of Veterans Affairs (VA) Medical Disability Exam program and any update to full-year guidance.
  • Policy-driven tailwind: New Medicaid rules requiring twice-yearly eligibility determinations and community-engagement (work) requirements take effect in early 2027, potentially expanding demand for Maximus's eligibility and program-administration services.
  • Strategic positioning: The company maintains a roughly 90% recompete win rate and a multi-billion-dollar backlog, anchored in entitlement programs with broad bipartisan support.
  • Margin sensitivity: A temporary suspension of performance incentives on the VA medical disability exam contract has pressured fiscal 2026 adjusted earnings guidance, a headwind to monitor.
  • Analyst sentiment: Consensus analyst coverage reflects a "Buy"-oriented stance, with a small but consistent pool of price targets clustered in the roughly $75 to $110 range.
  • Risks: Contract concentration (top contracts represent a large share of revenue), government budget cycles and award timing, and outstanding cybersecurity-related litigation could all alter the trajectory.
  • For additional detail on this company's Major News, Today's Price Move, Price Targets, and Earnings, explore these dedicated pages.
  • Readers seeking AI-driven market signals may also want to explore Trending AI Robots for additional perspective.

Strategic Positioning and Competitive Outlook

Maximus, Inc. is a leading provider of tech-enabled business process services (BPS), which means it runs large, complex administrative and clinical programs on behalf of government agencies. The company operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S., with U.S. Federal Services contributing the majority of revenue. Its customer base includes agencies such as the Centers for Medicare & Medicaid Services (CMS), the VA, the Internal Revenue Service (IRS), and the Transportation Security Administration (TSA).

Maximus's structural advantages include deep institutional knowledge of entitlement programs, a highly variable cost model, and long-tenured client relationships with contracts averaging well over seven years. A recompete win rate near 90% underscores the difficulty competitors face in displacing an incumbent that already operates mission-critical infrastructure at scale. The company's emphasis on artificial intelligence (AI) and automation—positioned internally as an early mover in applying these tools to government workflows—could support margin expansion and reinforce its competitive moat over the medium term.

The key structural risk is concentration: a small number of large contracts account for a substantial portion of revenue, so the loss or repricing of any major award can materially shift the outlook.

Major Catalysts Ahead

Several developments could meaningfully shape investor sentiment in the coming quarters. First, the fiscal 2026 fourth-quarter earnings release will provide a reset on whether the temporary suspension of performance incentives tied to the VA medical disability exam program has fully run its course, and whether management reaffirms or adjusts guidance for fiscal 2027.

Second, implementation of the Medicaid provisions of recent federal legislation is a significant medium-term driver. Beginning in January 2027, many states must conduct more frequent eligibility determinations and introduce work requirements for expansion populations. Because Maximus already provides eligibility support to numerous expansion states, this policy shift could translate into higher per-beneficiary activity levels and expanded scope on existing contracts.

Third, the company's sales pipeline—reported in the tens of billions of dollars—remains weighted toward new work, suggesting that award activity in 2027 and beyond could fuel organic growth even if near-term book-to-bill (the ratio of new awards to revenue) has been depressed by delayed federal procurement decisions.

On the analyst front, coverage remains thin but constructive. Consensus data from S&P Global-polled analysts reflects a "Buy" rating with an average 12-month price target in the low-to-mid $90s and a range spanning roughly $75 to $110. BTIG reaffirmed a Buy rating with a $100 price target in July 2026. While target revisions have been mixed as guidance evolved, the prevailing consensus stance suggests analysts remain net-positive on the company's longer-term positioning.

Industry and Macroeconomic Forces

Maximus's trajectory is closely tied to federal and state government budgets, which are influenced by political priorities rather than consumer demand cycles. Entitlement and health services programs benefit from relatively stable, mandatory funding, providing a degree of insulation from discretionary spending cuts. However, government shutdowns, continuing resolutions, and slower award decisions can delay new contract starts and payment collections.

Interest rates matter indirectly: higher borrowing costs can affect the company's cost of capital and debt service, while also influencing the valuation multiple investors apply to a mid-single-digit grower. Labor inflation is a direct cost input, though Maximus's variable cost structure and growing use of automation help mitigate margin pressure. Finally, the broader push toward digital government services and AI-enabled citizen experiences aligns favorably with the company's technology investments, positioning it to capture modernization-related spending.

Trend Prediction Engine

Tickeron's Trend Prediction Engine is an AI-powered forecasting tool designed to help traders assess whether a stock, exchange-traded fund (ETF), or other asset may trend bullish, bearish, or sideways over the coming week or month. It is intended to help users identify developing trends, evaluate potential breakouts or reversals, and compare predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality to support more timely decision-making. For investors monitoring Maximus and similar names, the platform offers a data-driven complement to fundamental analysis.

2026 Outlook and Long-Term Themes to Watch

Looking toward 2026 and beyond, Maximus's story centers on a handful of structural themes. AI and automation adoption offers a path to improved operating margins and differentiated bids in a competitive government-services market. Policy expansion—particularly the 2027 Medicaid redetermination and work-requirement mandates—could broaden the addressable market in the U.S. Services segment. Meanwhile, the VA medical disability exam program remains a bellwether for the Federal Services segment's profitability.

Capital allocation is another recurring theme: the company has repurchased a meaningful portion of its shares and raised its dividend, signaling management's confidence in free cash flow generation. Its stated priority remains internal organic investment ahead of buybacks and mergers and acquisitions (M&A), a disciplined approach that could support earnings per share growth even if revenue growth remains in the low single digits.

Consensus expectations suggest modest but positive growth, with analysts forecasting mid-single-digit earnings and revenue expansion. Key watch items include the pace of federal award activity, resolution of outstanding litigation, and whether new Medicaid work requirements generate the volume uplift management anticipates. These factors, rather than day-to-day price moves, are likely to determine the company's long-term investment narrative.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published Earnings

MMS is expected to report earnings to rise 4.05% to $2.31 per share on February 10

MAXIMUS MMS Stock Earnings Reports
Q4'26
Est.
$2.31
Q2'26
Beat
by $0.04
Q1'26
Beat
by $0.05
Q4'25
Beat
by $0.10
Q3'25
Beat
by $0.15
The last earnings report on August 06 showed earnings per share of $2.22, beating the estimate of $2.18. With 371.23K shares outstanding, the current market capitalization sits at 3.43B.
A.I.Advisor
published Dividends

MMS is expected to pay dividends on November 30, 2026

MAXIMUS MMS Stock Dividends
A quarterly dividend of $0.33 per share will be paid with a record date of November 30, 2026, and an ex-dividend date of November 13, 2026. The last dividend of $0.33 was paid on August 31. Read more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GOVZ32.710.04
+0.12%
iShares 25+ Year Treasury STRIPS Bond ETF (GOVZ)
NVDG18.84N/A
N/A
Leverage Shares 2X Long Nvda Daily ETF
FXB125.98-0.44
-0.35%
Invesco CurrencyShares British Pound Sterling Trust (FXB)
IMCB93.54-1.68
-1.76%
iShares Morningstar Mid-Cap ETF (IMCB)
STHH9.36-0.19
-2.03%
STMICROELECTRONICS NV ADRHEDGED

MMS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MMS has been loosely correlated with ICFI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MMS jumps, then ICFI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMS
1D Price
Change %
MMS100%
-5.00%
ICFI - MMS
44%
Loosely correlated
-1.94%
TRI - MMS
44%
Loosely correlated
-3.23%
BRC - MMS
42%
Loosely correlated
-1.98%
RELX - MMS
40%
Loosely correlated
-0.49%
BAH - MMS
39%
Loosely correlated
-1.67%
More

Groups containing MMS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMS
1D Price
Change %
MMS100%
-5.00%
Office Equipment/Supplies
industry (45 stocks)
-2%
Poorly correlated
+196.02%
Producer Manufacturing
industry (346 stocks)
-4%
Poorly correlated
+20.74%
A.I. Advisor
published General Information

General Information

a provider of business process services to government health and human services agencies

Industry OfficeEquipmentSupplies

Industry
Miscellaneous Commercial Services
Address
1600 Tysons Boulevard
Phone
+1 703 251-8500
Employees
37200
Web
https://www.maximus.com
Maximus (MMS) Stock Forecast: Federal Health Demand and AI Automation Could Define the Next Growth Phase